Current Report Filing (8-k)
December 17 2021 - 5:07AM
Edgar (US Regulatory)
0001779020
false
0001779020
2021-12-16
2021-12-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
United States
Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 16, 2021
DANIMER SCIENTIFIC, INC.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-39280
|
|
84-1924518
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
|
Identification Number)
|
140
Industrial Boulevard Bainbridge, Georgia
|
|
39817
|
(Address of principal executive
offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: (229) 243-7075
N/A
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
☒
Emerging growth company
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Class A Common stock, $0.0001 par value per share
|
|
DNMR
|
|
The New York Stock Exchange
|
Item 8.01 Other Events.
On December 16, 2021,
Danimer Scientific, Inc. (the “Company”) issued a press release relating to the pricing of its offering of 3.250% Convertible
Senior Notes due 2026 (the “Notes”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933,
as amended. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference
into this Item 8.01.
Neither this Current
Report on Form 8-K nor the press release constitutes an offer to sell, or the solicitation of an offer to buy, the Notes or the shares
of the Company’s common stock, if any, issuable upon conversion of the Notes.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
Dated: December 17, 2021
|
DANIMER SCIENTIFIC, INC.
|
|
|
|
|
By:
|
/s/ John A. Dowdy, III
|
|
Name:
|
John A. Dowdy, III
|
|
Title:
|
Chief Financial Officer
|
2
Live Oak Acquisition (NYSE:LOAK)
Historical Stock Chart
From Jul 2024 to Aug 2024
Live Oak Acquisition (NYSE:LOAK)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Live Oak Acquisition Corp (New York Stock Exchange): 0 recent articles
More Danimer Scientific, Inc. News Articles